Successors and Assigns Clause Example from Business Contracts
This example Successors and Assigns clause appears in 19 contracts from 15 companies
Sales Agreement, dated February 26, 2019, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 26, 2019)
Sales Agreement, dated February 27, 2020, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 27, 2020)
Sales Agreement, dated November 26, 2021, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 26, 2021)
Sales Agreement dated January 3, 2020 by and between MyoKardia, Inc. and Cowen and Company, LLC (Filed With SEC on January 3, 2020)
Sales Agreement, between the Company and Cowen and Company, LLC, dated as of August 4, 2022 (Filed With SEC on August 5, 2022)
Sales Agreement dated March 24, 2023 (Filed With SEC on March 24, 2023)
Common Stock Sales Agreement, dated June 15, 2018, by and between Trevena, Inc. and Cowen and Company, LLC (Filed With SEC on June 15, 2018)
TREVENA, INC. UP TO $40,000,000 OF SHARES COMMON STOCK SALES AGREEMENT (Filed With SEC on April 3, 2015)
TREVENA, INC. UP TO $75,000,000 OF SHARES COMMON STOCK SALES AGREEMENT (Filed With SEC on December 14, 2015)
Amended and Restated Sales Agreement, dated as of February 2, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on February 5, 2018)
Common Stock Sales Agreement, dated February 27, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on February 27, 2018)
Amended and Restated Sales Agreement, dated March 12, 2018, by and between Kura Oncology, Inc. and Cowen and Company, LLC (Filed With SEC on March 12, 2018)
Sales Agreement, dated March 30, 2018, by and between Senseonics Holdings, Inc. and Cowen and Company, LLC (Filed With SEC on March 30, 2018)
MIRAGEN THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on March 31, 2017)
GLYCOMIMETICS, INC. common Stock (par value $0.001 per share) SALES AGREEMENT (Filed With SEC on March 1, 2016)
KEMPHARM, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on October 3, 2016)
CATABASIS PHARMACEUTICALS, INC. $10,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on August 11, 2016)
CONTRAFECT CORPORATION UP TO $30,000,000 OF SHARES OF COMMON STOCK SALES AGREEMENT (Filed With SEC on January 20, 2016)
PROTEON THERAPEUTICS,INC. $40,000,000 cOMMON STOCK SALES AGREEMENT (Filed With SEC on November 12, 2015)